Webinar 3-1

De-Risking Innovation in Small Pharma and Biotech Clinical Research - Possible or Not?

 

ABOUT THE WEBINAR

Innovation in clinical operations is often deemed exclusive to big pharma, with seemingly endless budgets and resources. But what about biotech? Are they relegated to simply focusing on molecule development, devoid of innovation?
Join us as we explore:

  • Challenges biotech development groups tackle in clinical research.

  • Insights from seasoned professionals across biotech and mid-pharma.

  • Success strategies and key drivers in biotech drug development.

  • The pivotal role of innovation in overcoming biotech constraints.

Come learn from Yonalink and your other peers on how they balance on-trial innovation and successful trial delivery!

PANELISTS

Slick Playground

Joann Peters

Joann Peters

Chief Operating Officer, Geneos Therapeutics

Erika

Erika Talbott

Head of Customer and Site Success, Yonalink

Lauren

Lauren Briggs

SVP Customer Success, ProofPilot

Joseph Kim-1

Joseph Kim

Chief Strategy Officer, ProofPilot

Erin Boyle

Erin O’Boyle

VP, Clinical Operations, Rezolute, Inc.

Meraf

Meraf Eyassu

Executive Director, Clinical Operations, Terns Pharmaceuticals

FILL OUT THIS FORM TO ACCESS WEBINAR